Zepto IPO filing flags ED summons, CCI, CCPA risks

Zepto’s updated UDRHP puts risks front and centre

Zepto has filed an updated draft red herring prospectus (UDRHP) with SEBI for its proposed IPO, and the document is drawing attention for its detailed risk disclosures. Social media discussions have focused less on growth narratives and more on the range of regulatory and legal matters listed in the filing. The UDRHP outlines the company’s business expansion plans while repeatedly flagging uncertainty from ongoing proceedings. Zepto also highlights that it has reported losses in every financial year since its incorporation in July 2021. In the filing, the company cautions that it may continue to incur losses and negative operating cash flows as it scales. The updated document was filed with SEBI on June 8, 2026. It also states that the proposed public offering will comprise a fresh issue of shares worth ₹8,010 crore. The filing’s risk factors, including enforcement and consumer-related actions, are a key reason the stock market conversation has turned compliance-heavy.

ED summons under FEMA: what Zepto disclosed

One of the most discussed disclosures is that Zepto’s co-founders Aadit Palicha and Kaivalya Vohra received summons from the Enforcement Directorate (ED). The UDRHP says the summons were issued under the Foreign Exchange Management Act (FEMA), 1999. The summons are dated April 8, 2026, as per the updated filing. Zepto records this disclosure as Risk Factor 29 on page 46 of the DRHP. According to the filing, the ED sought information and documents related to foreign investments and overseas transactions. Zepto states that both founders appeared before the agency on multiple occasions. The company says documents and explanations were provided as requested by investigators. It also notes that the matter remains under examination and that no conclusions have been communicated as of the UDRHP filing date.

Timeline of appearances and the scope of information sought

The filing provides specific appearance dates for each founder, which has been widely cited in online discussions. Kaivalya Vohra appeared on April 17 and April 22, according to the disclosure. Aadit Palicha appeared on April 20 and May 15, the company states. The UDRHP says the ED asked for details that go beyond a narrow transaction-level query. It sought information on shareholding structures and business operations, as described in the document. The ED also asked for financial records, tax filings and bank accounts, as per the filing. The list described includes audited balance sheets since FY21. It also includes details on immovable properties, loans and guarantees, income tax returns, and a note on the company’s business model. Zepto’s language to investors is cautious, including an explicit warning that the matter could continue without a clear timeline for closure.

What the UDRHP says about potential escalation risk

Zepto’s filing includes forward-looking risk language around regulatory scrutiny, which is typical of prospectus risk sections but is notable for its specificity here. The company says it cannot assure investors that there will be no future inquiries. It also states it cannot guarantee the matter will not escalate into investigations, legal proceedings, or penalties. In the UDRHP, Zepto adds that as of the filing date it had not received further communication from the ED since submitting its response. At the same time, it frames that status as provisional rather than conclusive. The company’s disclosure emphasises that the matter is still under examination. It also flags that uncertainty could persist without a defined endpoint. For IPO-bound companies, this type of disclosure helps set expectations around regulatory timelines. For investors, it becomes a key due diligence point because it can influence operational focus and management bandwidth.

CCI scrutiny: quick commerce pricing and competition claims

Beyond FEMA-related inquiries, Zepto’s filing references scrutiny from the Competition Commission of India (CCI). The UDRHP says the CCI is examining allegations related to pricing practices and competition in quick commerce. It specifically notes an active inquiry into predatory pricing and anti-competitive discounting in which Zepto has been named. The company’s disclosure places the CCI matter alongside other regulatory proceedings as a material risk factor. This has resonated on social media because quick commerce competition is closely linked to discounting strategies. The filing does not present an outcome, and it does not state that the CCI has reached any conclusion. Instead, it indicates ongoing examination and the existence of allegations under review. For the market, the presence of a named inquiry can affect how investors assess sustainability of customer acquisition tactics. The UDRHP positions the risk as one that could impact business operations depending on how the inquiry progresses.

CCPA “dark patterns” case and the ₹7 lakh penalty

Another point highlighted in the UDRHP is consumer protection oversight involving the Central Consumer Protection Authority (CCPA). The filing references alleged “dark patterns” on Zepto’s platform, including basket sneaking, misleading advertisements, and drip pricing practices. According to the disclosure, the CCPA imposed a penalty of ₹7 lakh on Zepto for non-compliance with guidelines related to dark patterns. Zepto has challenged the order before the National Consumer Disputes Redressal Commission (NCDRC). The UDRHP states that the NCDRC has granted an interim stay in the matter. Despite the stay, Zepto cautions investors about the potential impact of adverse rulings. It also warns that changes in the interpretation of applicable laws and regulations could affect operations and financial performance. This disclosure has become a focal point because it links user interface design decisions to regulatory exposure.

Other proceedings listed: labour, licensing, and food safety matters

Zepto’s UDRHP also discloses multiple fresh regulatory and labour-related proceedings that remain pending. These include allegations of underpayment of wages in Karnataka, as stated in the context shared from the filing. The UDRHP also mentions operating a Tamil Nadu dark store without a valid trade licence. It further references wage payment complaints in Haryana and industrial disputes in Gujarat. In addition, the filing notes food safety violations linked to mustard oil and sattu samples in Uttar Pradesh. The disclosure does not claim that these matters have been resolved, and it describes them as pending. Social media discussion around these points has focused on execution risks that come with rapid network expansion. The UDRHP groups these items as operational and compliance exposures rather than one-off issues.

Regulatory order at Dharavi: FDA suspension details

Separately, the context also mentions a food regulatory action involving Zepto’s Dharavi facility in Mumbai. It states that on May 31, 2025, the Food and Drug Administration conducted an inspection of the Dharavi warehouse of Kiranakart Technologies. Following the inspection, the FDA suspended the Dharavi unit’s licence and stopped operations there, as described in the shared details. The note clarifies that the suspension was a regulatory measure under the Food Safety Act, rather than a court-driven dispute. It also states that no related court order, summons, or judicial complaint was filed in relation to this issue. The directive is described as being issued under Section 32(3) of the Food Safety and Standards Act and Regulation 2.1.8(4). For IPO readers, the distinction matters because regulatory actions and judicial proceedings can follow different timelines and remedies. This is also an example of how operational compliance at facility level can become a material disclosure item. The broader takeaway in the UDRHP context is that multiple regulators can be relevant to a quick commerce business.

Court actions involving the Zepto brand and impersonation risks

The context also includes court developments related to the Zepto brand, which are different from the ED and regulator-led proceedings. In one matter, the Delhi High Court granted an ex-parte ad-interim injunction restraining defendants from operating fake domain names, websites and applications using the ‘Zepto’ trademark. The order directed suspension, deletion and takedown of websites, applications and social media accounts soliciting payments for fake job opportunities and franchises. The matter was listed for further adjudication on February 18, 2026, as referenced. Separately, the Delhi High Court allowed Kiranakart Technologies’ rectification application against an identical “ZEPTO” trademark in Class 35. The context states that the court ordered removal of a third-party registration on grounds of non-use for more than five years, under Section 47(1)(b) of the Trade Marks Act. The result provided relief to Zepto’s parent company and enabled it to legally register the trademark under Class 35, as described. These matters have been discussed online as examples of the brand’s exposure to impersonation and the importance of trademark housekeeping.

Snapshot table: what the filing and reports highlight

The UDRHP and related updates surface a broad set of matters, each with different legal standards and possible outcomes. The table below summarises what has been described in the shared context and how Zepto has characterised status where mentioned.

Why these disclosures matter ahead of an IPO

The updated UDRHP shows how Zepto is positioning its risk narrative for public market investors. It combines business scaling disclosures with explicit statements about regulatory uncertainty, including the possibility of further inquiries. The ED summons disclosure, with dates and document scope, is unusually detailed for general readers and has driven discussion online. The CCI and CCPA matters highlight that fast-growth consumer platforms can face scrutiny from both competition and consumer protection regulators. The filing also surfaces compliance issues at the operational layer, such as wages, licences and food safety sampling disputes. On the legal side, the Delhi High Court actions show that brand impersonation and trademark conflicts can be material, even when not tied to core operations. Importantly, the company states that some matters have no clear timeline for closure, which is relevant for IPO risk pricing. The UDRHP does not indicate any ED conclusion as of the filing date, and it does not state any final outcomes for the CCI inquiry described. For investors tracking the proposed issue, the document’s overall message is that growth is being pursued alongside multiple live regulatory threads, and the company is disclosing that uncertainty directly.